HLA-C and cancer: Despite limited understanding of γδ TCR ligand recognition, there is already substantial therapeutic interest in γδ T cells, particularly in the cancer immunotherapy arena, not least due to their MHC-unrestricted recognition of target cells and potent cytotoxic function.